1.Relationship between matrix metalloproteinase-9 and type 2 diabetic macroangiopathy and the effect of Simvastatin
Kuanzhi LIU ; Yajing CHEN ; Taoran JIN
Chinese Journal of Practical Internal Medicine 2001;0(03):-
Objective To investigate the association between matrix metalloproteinase 9(MMP 9) and type 2 diabetic macroangiopathy and explain the mechanism of Simvastatin protective effects on blood vessel.Methods The serum MMP 9 was determined by ELISA in 40 healthy controls and 80 type 2 diabetes(including 40 type 2 diabetic macroangiopathy and 40 type 2 diabetes without complications) before and after Simvastatin treatment.Results The serum MMP 9 in type 2 diabetic macroangiopathy was higher than that in type 2 diabetes without complications and healthy controls.Serum MMP 9 was correlated positively with TC,LDL C,Ox LDL and blood pressure and correlated negatively with HDL C. After Simvastatin treatment,the levels of serum MMP 9 were reduced and serum TC,LDL C and Ox LDL were also decreased.Conclusion MMP 9 may play an important role in the development and progression of type 2 diabetic macroangiopathy.The protective effects of Simvastatin on blood vessel partly attribute to its lowering of serum MMP 9.
2.Study on surface electromyography characteristics of human upper limb during daily living activities.
Haiyan SONG ; Jianguo ZHANG ; Taoran LIU ; Shaopeng GAO
Journal of Biomedical Engineering 2009;26(6):1177-1180
This study on the surface electromyography (sEMG) characteristics of human upper limb during the Activities of Daily Living (ADLs) was aimed to deliberate over the precise evaluation index for the muscle function of human upper limb, and for the significance of muscle function prediction, diagnosis and rehabilitation evaluation, thus providing the design parameters for prosthetic devices. 20 normal adults (10 males and 10 females) were recruited. They each performed 13 basic actions of left and right upper limb; then they repeated each action 3 times. The sEMG signals of ten muscles (the middle of deltoid, biceps brachii, triceps brachii, palmaris longus, extensor digitorum) were tested by 8-channel sEMG collected system. The eigenvalue of Average electromyography (AEMG) and Integral electromyography (IEMG) were processed by SPSS 14. 0. The sEMG characteristics of main muscles (the middle of deltoid, biceps brachii, triceps brachii, palmaris longus, extensor digitorum) during the ADLs were obtained and analyzed. The conclusion is that Man and Woman should be different in using muscle force; man should focus on the strength of extensor digitorum, while woman should enhance the strength of palmaris longus when the elderly and the disabled performed rehabilitation training. Biceps brachii is important both in man and woman during the ADLs; deltoid and triceps brachii are less important. There is no significant difference in sEMG between left and right main muscles. At the same time, AEMG is consistent with IEMG in evaluating the muscle function.
Activities of Daily Living
;
Adult
;
Electromyography
;
Female
;
Humans
;
Male
;
Muscle, Skeletal
;
physiology
;
Sex Factors
;
Upper Extremity
;
Young Adult
3.Musculoskeletal System Anatomic Database Software Applied to the Internet.
Hai ZHOU ; Taoran LIU ; Dongmei WANG
Chinese Journal of Medical Instrumentation 2019;43(4):248-251
We developed a new the musculoskeletal anatomic database software based on internet. This article presents the design objective and basic routes of the software, further present the technical plan, software functionality and service objects. This software is used to store the anatomic data of musculoskeletal system, that allows the users to enquire and do statistial analysis through the large amount of anatomic data, that guides the doctors to design operative schemes, that provides technical supports for medicine and industry fields.
Databases, Factual
;
Humans
;
Internet
;
Musculoskeletal System
;
Software
;
User-Computer Interface
4.Factors related to re-falling of knee range of motion after arthrolysis for post-traumatic knee stiffness
Zhigang CUI ; Taoran JIN ; Sihai LIU ; Fei WANG ; Kemin LIU ; Jianjun LI
Chinese Journal of Rehabilitation Theory and Practice 2024;30(5):565-569
Objective To observe the temporary loss(re-falling)of knee range of motion(ROM)during rehabilitation after arthroly-sis for post-traumatic knee stiffness,and analyze the factors related to it. Methods From July,2016 to September,2019,64 patients(68 knees)in Beijing Bo'ai Hospital accepted minimally inva-sive arthrolysis for post-traumatic knee stiffness,and were followed up for twelve months.ROM of flexion and extension of knee was measured before operation,and one,six and twelve weeks,and six and twelve months af-ter operation;while they were asssessed with Hospital for Special Surgery Knee Score(HSS).Multivariate Logis-tic regression was performed on re-falling. Results The ROM and HSS score improved as a whole after operation;however,HSS score improved constantly,but ROM decreased six weeks after operation compared with that one weeks after operation,involving 46 knees of 44 cases.Arthrolysis longer than 12 months from primary injuries,multiple complicated fracture and history of infection were the risk factors for re-falling(OR>8.058,P<0.05). Conclusion Minimally invasive arthrolysis is effective on knee function after arthrolysis for post-traumatic knee stiff-ness.However,re-falling of ROM may happen during rehabilitation.Delay of operation,multiple complicated fracture and history of infection may increase the risk of re-falling.
5.Advances of using microfluidic chips for research and diagnosis of pulmonary inflammatory diseases.
Taoran XIA ; Wei ZOU ; Jing LIU
Chinese Journal of Biotechnology 2021;37(11):3905-3914
Microfluidic chip technology integrates the sample preparation, reaction, separation and detection on a chip. It consists a network of microchannels, which controls the whole system through fluid. With the advantages of portability, high throughput, and the ability to simulate the microenvironment in vivo, it has a broad application prospect in the research of disease diagnosis, pathogenesis and drug screening. Pulmonary inflammatory disease is a common disease usually caused by bacterial, viral and fungal infections. Early pneumonia is often difficult to diagnose due to lack of obvious respiratory symptoms or the symptoms are mostly atypical, but the disease progresses rapidly. Recently, microfluidic chip technology has been increasingly used to the study of pulmonary inflammatory diseases. In particular, it has been used to develop a "lung-on-a-chip" model, which can reproduce the key structure, function and mechanical properties of human alveolar capillary interface (i.e., the basic functional unit of a living lung), and well simulate the alveoli in vitro. Compared with the cell and animal models, this multifunctional micro experimental platform has great advantages. This article summarizes the advances of using microfluidic chips for the research and diagnosis of pulmonary inflammatory diseases, with the aim to provide new ideas for researchers in this area.
Animals
;
Drug Evaluation, Preclinical
;
Humans
;
Lung
;
Microfluidic Analytical Techniques
;
Microfluidics
6.Interpretation of subjective cognitive decline characteristics published in Lancet Neurology
Yu SUN ; Xiaoni WANG ; Guanqun CHEN ; Can SHENG ; Xuanyu LI ; Qin YANG ; Taoran LI ; Wenying DU ; Xiaoqi WANG ; Li LIN ; Yi LIU ; Feng FENG ; Xiaochen HU ; Ying HAN
Chinese Journal of Neurology 2020;53(5):396-400
Alzheimer′s disease (AD) is an incurable disease in the field of major chronic diseases. Subjective cognitive decline (SCD) is a clinical risk factor for AD. The standardized screening and intervention in individuals with SCD are of great importance in early prevention and treatment of AD. According to the clinical criteria proposed by The characterisation of subjective cognitive decline, which was published online in Lancet Neurology, the article summarized the definition of SCD, the latest perspective of clinical standards in SCD, and the results of AD preclinical SCD research. The purpose of this work was to provide concrete guidance and recommendations for making clinical decisions in diagnosis and scientific research on SCD.
7.Saponins in Treatment of Alzheimer's Disease and Their Mechanism of Action: A Review
Taoran LI ; Xiaoqing ZHOU ; Hongdong LIU ; Dongmei YAN ; Shan LIU ; Bin LI
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(14):216-225
Alzheimer's disease(AD) is an irreversible neurodegenerative disease with clinical manifestations such as memory impairment, aphasia, impaired visuospatial skills, executive function impairment, and personality changes. AD has brought a heavy burden to the family and society due to its unrevealed pathogenesis and the lack of therapeutic approaches. Saponins, a group of oligoglycosides whose aglycones are triterpenes or spirosteroids, are divided into triterpene saponins and steroidal saponins, which have a variety of biological activities. At present, there is no systematic review on the anti-AD effect of saponins. According to the literature published in recent years, the authors summarized the studies of saponins in improving AD based on animal experiments. The results indicated that saponins enhanced learning ability and improved cognitive impairment by inhibiting amyloid β-protein (Aβ) cascade activity, suppressing microtubule-associated protein (tau) hyperphosphorylation, inhibiting neuronal oxidative stress, inhibiting inflammatory factors, regulating apoptosis, inhibiting cholinergic neuronal degeneration, promoting mitochondrial autophagy, regulating intestinal flora, and enhancing energy metabolism, which in turn improved the pathological state of AD animal models. The therapeutic effects of different saponins on AD are different. The present study discussed the effect of different aglycones and sugar chains on the anti-AD activity based on saponins and anti-AD effect to provide new ideas and a theoretical basis for the development and utilization of saponins.
8.The degradation of plastics and the production of polyhydroxyalkanoates (PHA).
Zonghao ZHANG ; Hongtao HE ; Xu ZHANG ; Shuang ZHENG ; Taoran ZHENG ; Xu LIU ; Guoqiang CHEN
Chinese Journal of Biotechnology 2023;39(5):2053-2069
In recent years, the petroleum-based plastic pollution problem has been causing global attention. The idea of "degradation and up-cycling of plastics" was proposed for solving the environmental pollution caused by non-degradable plastics. Following this idea, plastics would be firstly degraded and then reconstructed. Polyhydroxyalkanoates (PHA) can be produced from the degraded plastic monomers as a choice to recycle among various plastics. PHA, a family of biopolyesters synthesized by many microbes, have attracted great interest in industrial, agricultural and medical sectors due to its biodegradability, biocompatibility, thermoplasticity and carbon neutrality. Moreover, the regulations on PHA monomer compositions, processing technology, and modification methods may further improve the material properties, making PHA a promising alternative to traditional plastics. Furthermore, the application of the "next-generation industrial biotechnology (NGIB)" utilizing extremophiles for PHA production is expected to enhance the PHA market competitiveness, promoting this environmentally friendly bio-based material to partially replace petroleum-based products, and achieve sustainable development with carbon-neutrality. This review summarizes the basic material properties, plastic upcycling via PHA biosynthesis, processing and modification methods of PHA, and biosynthesis of novel PHA.
Polyhydroxyalkanoates
;
Plastics
;
Biotechnology
;
Petroleum
;
Carbon
9.Domestic self-expanding interventional pulmonary valve stent in transthoracic implantation for pulmonary valve regurgitation: A prospective cohort study
Ziqin ZHOU ; Taoran HUANG ; Naijimuding ABUDUREXITI ; Yong ZHANG ; Haiyun YUAN ; Nianjin XIE ; Hongwen FEI ; Hui LIU ; Jian ZHUANG ; Jimei CHEN ; Shusheng WEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(09):1305-1312
Objective To analyze and summarize the early and medium-term outcomes of self-expanding interventional pulmonary valve stent (SalusTM) for right ventricular outflow tract dysfunction with severe pulmonary valve regurgitation. Methods We established strict enrollment and follow-up criteria. Patients who received interventional pulmonary valve in transthoracic implantation in Guangdong Provincial People’s Hospital from September 2, 2021 to July 18, 2023 were prospectively included, and all clinical data of patients were collected and analyzed. Results A total of 38 patients with severe pulmonary regurgitation were included, with 23 (60.5%) males and 15 (39.5%) females. The mean age was 24.08±8.12 years, and the mean weight was 57.66±13.54 kg. The preoperative mean right ventricular end-diastolic volume index (RVEDVI) and right ventricular end-systolic volume index (RVESVI) were 151.83±42.84 mL/m2 and 83.34±33.05 mL/m2, respectively. All patients successfully underwent transcatheter self-expandable pulmonary valve implantation, with 3 (7.9%) patients experiencing valve stent displacement during the procedure. Perioperative complications included 1 (2.6%) patient of postoperative inferior wall myocardial infarction and 1 (2.6%) patient of poor wound healing. The median follow-up time was 12.00 (6.00, 17.50) months. During the follow-up period, there were no deaths or reinterventions, and no patients had recurrent severe pulmonary regurgitation. Three (7.9%) patients experienced chest tightness and chest pain, and 1 (2.6%) patient developed frequent ventricular premature beats. Compared with preoperative values, the right atrial diameter, right ventricular diameter, and tricuspid annular plane systolic excursion were significantly reduced at 6 months and 1 year postoperatively, with improvement in the degree of pulmonary regurgitation (P<0.01). Compared with preoperative values, RVEDVI and RVESVI decreased to 109.51±17.13 mL/m2 and 55.88±15.66 mL/m2, respectively, at 1 year postoperatively (P<0.01). Conclusion Self-expanding interventional pulmonary valve in transthoracic implantation is safe and effective for severe pulmonary valve regurgitation and shows good clinical and hemodynamic results in one-year outcome.